Bill

Bill > SRes510


US SRes510

US SRes510
A resolution expressing the sense of the Senate that the scientific judgement of the Food and Drug Administration that mifepristone is safe and effective should be respected, and law and policy governing access to lifesaving, time-sensitive medication abortion care in the United States should be equitable and based on science.


summary

Introduced
12/14/2023
In Committee
12/14/2023
Crossed Over
Passed
Dead
01/03/2025

Introduced Session

118th Congress

Bill Summary

RESOLUTION Expressing the sense of the Senate that the scientific judgment of the Food and Drug Administration that mifepristone is safe and effective should be respected, and law and policy governing access to lifesaving, timesensitive medication abortion care in the United States should be equitable and based on science.

Committee Categories

Health and Social Services

Sponsors (42)

Elizabeth Warren (D)* Tammy Baldwin (D),  Michael Bennet (D),  Richard Blumenthal (D),  Cory Booker (D),  Sherrod Brown (D),  Laphonza Butler (D),  Maria Cantwell (D),  Tom Carper (D),  Catherine Cortez Masto (D),  Tammy Duckworth (D),  Dick Durbin (D),  John Fetterman (D),  Kirsten Gillibrand (D),  Maggie Hassan (D),  Martin Heinrich (D),  John Hickenlooper (D),  Mazie Hirono (D),  Mark Kelly (D),  Angus King (I),  Amy Klobuchar (D),  Ed Markey (D),  Bob Menendez (D),  Jeff Merkley (D),  Chris Murphy (D),  Patty Murray (D),  Jon Ossoff (D),  Alex Padilla (D),  Jack Reed (D),  Jacky Rosen (D),  Bernie Sanders (I),  Brian Schatz (D),  Chuck Schumer (D),  Jeanne Shaheen (D),  Kyrsten Sinema (I),  Tina Smith (D),  Debbie Stabenow (D),  Chris Van Hollen (D),  Raphael Warnock (D),  Peter Welch (D),  Sheldon Whitehouse (D),  Ron Wyden (D), 

Last Action

Referred to the Committee on Health, Education, Labor, and Pensions. (text: CR S6003-6004) (on 12/14/2023)

bill text


bill summary

Loading...

bill summary

Loading...
Loading...